Celdara Medical, LLC has been recognized as the fastest growing company in the State of New Hampshire by Business NH Magazine. This award is based on 3-year average revenue growth, where Celdara delivered a 193% AAGR, leading all companies in all categories. This is the 5th consecutive year that Celdara […]
Celdara Medical and The Geisel School of Medicine at Dartmouth today announced the selection of two outstanding researchers as the recipients of the 2017 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships (DS-CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara Medical to graduate student and post-doctoral researchers affiliated […]
Celdara Medical, LLC today announced that it has successfully concluded negotiations with Celyad SA (Euronext Brussels and Paris, and NASDAQ:CYAD) related to their ongoing partnership for discovery and development of CAR T cell therapies. Celyad, a Belgium-based cell therapy company, obtained access to its CAR T cell drug product candidates […]
Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health has awarded a two-year, $2 million Phase II Small Business Innovation Research grant to fund the company’s development of a B cell focused immunotherapy to treat melanoma and other cancers. The biologic, CM-JG01, targets […]
The U.S. Small Business Administration and the New Hampshire Bankers Association announced its 2017 New Hampshire Small Business Award winners Friday, recognizing outstanding small business owners throughout the state. Jake Reder, Ph.D., co-founder and CEO of Celdara Medical LLC of Lebanon, was selected as SBA’s New Hampshire Small Business Person […]
Celdara Medical, LLC (Celdara) today announced that it has been recognized as the fastest growing company in the State of New Hampshire by Business NH Magazine. This award is based on 3-year average revenue growth, where Celdara delivered an average 198% growth rate, leading all companies in all categories. This […]
Celdara Medical, LLC today announced the opening of a new office in the Washington D.C. Metropolitan Area. Celdara Medical currently has offices in Greater Boston and New York City, and affiliates in Seattle (Virtici) and Indianapolis (MBV). “This expansion is a direct reflection of the importance of the D.C. region […]
Celdara Medical, LLC announced receipt of a clinical milestone payment from partner Celyad, SA (NASDAQ: CYAD). This milestone payment is related to the advancement of the OnCyte product candidate CM-CS1, currently in Phase I clinical development (NCT02203825) at the Dana Farber Cancer Institute. OnCyte was acquired by Celyad from Celdara […]
Today Celdara Medical, Virtici, and MBV announced their formation of the first collaborative nationwide network for the development of early stage biotechnologies. The goals are simple: to improve human health by identifying the highest potential innovations in medicine, and developing them into the clinic. The companies share a highly collaborative […]
Celdara Medical, LLC and Pulmatrix, Inc. (NASDAQ: PULM) today announced that the National Heart Lung and Blood Institute of the National Institutes of Health has awarded a three-year, $1.7 million Fast Track Small Business Innovation Research grant to fund the companies’ development of an inhaled biologic to treat idiopathic pulmonary […]